These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Relationship of tumor marker CA125 and ovarian tumor stem cells: preliminary identification. Zhang H, Yang Y, Wang Y, Gao X, Wang W, Liu H, He H, Liang Y, Pan K, Wu H, Shi J, Xue H, Liang L, Cai Z, Fan Y, Zhang Y. J Ovarian Res; 2015 Mar 28; 8():19. PubMed ID: 25886959 [Abstract] [Full Text] [Related]
23. [The role of CA125 in the differential diagnosis of primary ovarian carcinoma and metastatic ovarian carcinoma originated from the gastrointestinal tract]. Yang W, Zhang T, Fan J. Zhonghua Fu Chan Ke Za Zhi; 2001 May 28; 36(5):302-3. PubMed ID: 11783384 [Abstract] [Full Text] [Related]
24. Combined detection of sialic acid and hydroxyproline in diagnosis of ovarian cancer and its comparison with human epididymis protein 4 and carbohydrate antigen 125. Li PL, Zhang X, Li TF, Wang LL, Du LT, Yang YM, Li J, Wang HY, Zhang Y, Wang CX. Clin Chim Acta; 2015 Jan 15; 439():148-53. PubMed ID: 25445414 [Abstract] [Full Text] [Related]
25. Microarray Glycoprofiling of CA125 improves differential diagnosis of ovarian cancer. Chen K, Gentry-Maharaj A, Burnell M, Steentoft C, Marcos-Silva L, Mandel U, Jacobs I, Dawnay A, Menon U, Blixt O. J Proteome Res; 2013 Mar 01; 12(3):1408-18. PubMed ID: 23360124 [Abstract] [Full Text] [Related]
26. [Clinical value of serum CA19-9, CA125 and CP2 in mucinous ovarian tumor: a retrospective study of 273 patients]. Dong L, Cui H, Li XP, Sun LF, Chang XH, Liang XD, Zhu HL. Zhonghua Fu Chan Ke Za Zhi; 2008 Jan 01; 43(1):5-8. PubMed ID: 18366923 [Abstract] [Full Text] [Related]
29. The role of CA125 in clinical practice. Moss EL, Hollingworth J, Reynolds TM. J Clin Pathol; 2005 Mar 01; 58(3):308-12. PubMed ID: 15735166 [Abstract] [Full Text] [Related]
30. Evaluation of the accuracy of serum human epididymis protein 4 in combination with CA125 for detecting ovarian cancer: a prospective case-control study in a Korean population. Kim YM, Whang DH, Park J, Kim SH, Lee SW, Park HA, Ha M, Choi KH. Clin Chem Lab Med; 2011 Mar 01; 49(3):527-34. PubMed ID: 21320028 [Abstract] [Full Text] [Related]
34. [Diagnostic value of multiple tumor marker detection for mature and immature teratoma of the ovary]. Chen C, Li JD, Huang H, Feng YL, Wang LH, Chen L. Ai Zheng; 2008 Jan 01; 27(1):92-5. PubMed ID: 18184473 [Abstract] [Full Text] [Related]
36. [The value of urine cystein proteinase and serum CA125 measurement in monitoring the treatment of malignant ovarian tumor]. Gao G, Peng Z, He B. Hua Xi Yi Ke Da Xue Xue Bao; 1996 Sep 01; 27(3):291-4. PubMed ID: 9389065 [Abstract] [Full Text] [Related]
37. Role of tumour markers in monitoring epithelial ovarian cancer. Meyer T, Rustin GJ. Br J Cancer; 2000 May 01; 82(9):1535-8. PubMed ID: 10789720 [Abstract] [Full Text] [Related]
38. [Application of multi-tumor markers in ovarian carcinoma]. Feng J, Qian H, Tian Y. Zhonghua Fu Chan Ke Za Zhi; 1998 May 01; 33(5):284-6. PubMed ID: 10682440 [Abstract] [Full Text] [Related]
39. Significance of tumor marker determinations in the primary therapy of ovarian cancer. Meier W, Baumgartner L, Stieber P, Hasholzner U, Fateh-Moghadam A. Anticancer Res; 1997 May 01; 17(4B):2949-51. PubMed ID: 9329572 [Abstract] [Full Text] [Related]
40. Tissue polypeptide specific antigen and cancer associated serum antigen in the follow-up of ovarian cancer. Sliutz G, Tempfer C, Kainz C, Mustafa G, Gitsch G, Koelbl H, Biegelmayer C. Anticancer Res; 1995 May 01; 15(3):1127-9. PubMed ID: 7645936 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]